These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2204718)

  • 21. Reliability of echocardiographic measurements of myocardial perfusion using commercially produced sonicated serum albumin (Albunex).
    Klein AL; Bailey AS; Moura A; Murray RD; Morehead AJ; Brum J; Pearce G; Stewart WJ; Thomas JD
    J Am Coll Cardiol; 1993 Dec; 22(7):1983-93. PubMed ID: 8245358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative measurements of second harmonic Doppler using ultrasound contrast agents.
    Chang PH; Shung KK; Levene HB
    Ultrasound Med Biol; 1996; 22(9):1205-14. PubMed ID: 9123645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acoustic cavitation nuclei survive the apparent ultrasonic destruction of Albunex microspheres.
    Brayman AA; Miller MW
    Ultrasound Med Biol; 1997; 23(5):793-6. PubMed ID: 9253828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental study of stability of a contrast agent in an ultrasound field.
    Wu J; Tong J
    Ultrasound Med Biol; 1998 Feb; 24(2):257-65. PubMed ID: 9550184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of various agents in contrast enhancement of color Doppler flow images: an in vitro study.
    Fan P; Czuwala PJ; Nanda NC; Rosenthal SM; Yoganathan A
    Ultrasound Med Biol; 1993; 19(1):45-57. PubMed ID: 8456528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
    Bouakaz A; de Jong N; Cachard C; Jouini K
    Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound scattering properties of Albunex microspheres.
    de Jong N; Hoff L
    Ultrasonics; 1993; 31(3):175-81. PubMed ID: 8484195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The experimental investigation of ultrasonic properties for a sonicated contrast agent and its application in biomedicine.
    Zhang D; Gong XF; Liu JH; Shao LZ; Li XR; Zhang QL
    Ultrasound Med Biol; 2000 Feb; 26(2):347-51. PubMed ID: 10722925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of contrast agents for delineation of vessel wall boundary by intracoronary ultrasound after coronary angioplasty in human.
    Nishino M; Tanouchi J; Kawabata M; Tanaka K; Ito T; Kato J; Yamada Y; Kamada T
    Catheter Cardiovasc Interv; 1999 May; 47(1):6-13. PubMed ID: 10385151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broadband measurements of phase velocity in Albunex suspensions.
    Mobley J; Marsh JN; Hall CS; Hughes MS; Brandenburger GH; Miller JG
    J Acoust Soc Am; 1998 Apr; 103(4):2145-53. PubMed ID: 9566335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements.
    de Jong N; Hoff L; Skotland T; Bom N
    Ultrasonics; 1992 Mar; 30(2):95-103. PubMed ID: 1557838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric microballoons as ultrasound contrast agents. Physical and ultrasonic properties compared with sonicated albumin.
    Schneider M; Bussat P; Barrau MB; Arditi M; Yan F; Hybl E
    Invest Radiol; 1992 Feb; 27(2):134-9. PubMed ID: 1376304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex.
    Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE
    Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission measurements of Albunex attenuation and phase velocity at concentrations approaching in vivo doses.
    Adams M; Marsh JN; Hall CS; Mobley J; Hughes MS; Miller JG; Brandenburger GH
    Acad Radiol; 1996 Aug; 3 Suppl 2():S182-4. PubMed ID: 8796556
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous Albunex during transesophageal echocardiography: quantitative assessment by videodensitometry and integrated backscatter analysis from unprocessed radiofrequency signals.
    Angermann CE; Krüger TM; Junge R; Drewello R; Stempfle HU; Spes CH; Theisen K
    J Am Soc Echocardiogr; 1995; 8(6):839-53. PubMed ID: 8611284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of an immune response to Albunex, a new ultrasound contrast agent based on air-filled albumin microspheres.
    Christiansen C; Vebner AJ; Muan B; Vik H; Haider T; Nicolaysen H; Skotland T
    Int Arch Allergy Immunol; 1994 Aug; 104(4):372-8. PubMed ID: 8038616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents.
    Miller DL; Gies RA
    Ultrasound Med Biol; 1998 Feb; 24(2):285-92. PubMed ID: 9550187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between air-filled albumin microbubble and red blood cell rheology in the human myocardium. Influence of echocardiographic systems and chest wall attenuation.
    Ismail S; Jayaweera AR; Camarano G; Gimple LW; Powers ER; Kaul S
    Circulation; 1996 Aug; 94(3):445-51. PubMed ID: 8759087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation.
    Vogel R; Indermühle A; Reinhardt J; Meier P; Siegrist PT; Namdar M; Kaufmann PA; Seiler C
    J Am Coll Cardiol; 2005 Mar; 45(5):754-62. PubMed ID: 15734622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pressure on echocardiographic videodensity from sonicated albumin: an in vitro model.
    Gottlieb S; Ernst A; Meltzer RS
    J Ultrasound Med; 1995 Feb; 14(2):109-16. PubMed ID: 8568955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.